ESC 365 - HbA1c variability is associated with adverse outcomes in heart failure patients with and without diabetes

ESC Professional Premium Access

HbA1c variability is associated with adverse outcomes in heart failure patients with and without diabetes

Session: Special Populations

Topic: Epidemiology, Prognosis, Outcome

Speaker: Doctor Q. Ren (CN)

Event: ESC Asia 2022 with APSC & AFC

Congress Presentation

Add to my library

About the speaker

Doctor Qingwen Ren

(China)

1 follower

3 more presentations in this session

An updated meta-analysis: The effect of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in the mortality of hypertensive patients with confirmed COVID-19 infection

Speaker: Doctor M. Manalili (San Juan, PH)

Prevalence, mortality, and disability-adjusted-life-years resulting from aortic aneurysm burden and its association with the socio-demographic index in Asia, 1990-2019: Results from the GBD 2019

Speaker: Professor L. Gobolos (Abu Dhabi, AE)

Key comorbidities and laboratory findings: insights from first prospective, observational and Multi-Center Malaysia Heart Failure (MYHF) registry

Speaker: Professor W. Wan Ahmad (Kuala Lumpur, MY)

Access the full session

Special Populations

Speakers: Doctor Q. Ren, Doctor M. Manalili, Professor L. Gobolos, Professor W. Wan Ahmad

About the event

ESC Asia 2022 with APSC & AFC

1 December - 3 December 2022

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources